AGL 2043 T26576
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AGL 2043 is a potent, reversible, ATP-competitive inhibitor of type III receptor tyrosine kinases.
CAS nr:
226717-28-8
Purity:
98%
Molecular Weight:
280,35
SMILES:
CC(N1C)=NC2=C1C=C3N=CC(C4=CC=CS4)=NC3=C2
Formula:
C15H12N4S
Pathway:
Target:
